AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...

COSMIC (molecular conformation space modeling in internal coordinates) can provide important insights into the 3D positioning and activity of molecules to help drive decisions about drug design. While ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I identify how the use of world models is ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the intriguing and quite ...

This schematic illustrates the integrated AI for Materials (AI4M) framework proposed for OLED material design. It starts from (I) Basic Luminescent Materials, focusing on structural and photophysical ...

In brief: Companies involved in the generative AI business keep making outrageous promises about unprecedented productivity improvements and cost cuts. Meta is now focusing on 3D model creation, which ...